Skip to content
Biotechnology

Stronger, safer, smarter: pioneering Zinc-based dissolvable implants for better bone repair

Monash University 2 mins read

Monash research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold fractured bones together. 

Surgeons routinely use stainless steel or titanium, which stay in the body forever, can cause discomfort and may require follow-up surgeries. A new zinc alloy, designed by Monash biomedical engineers, could solve these problems by being mechanically strong but gentle enough to degrade safely over time while supporting optimal healing.

A study published today in Nature shows the research team’s innovative approach to making the zinc alloy as strong as permanent steel implants and more durable than other biodegradable options like magnesium-based implants.

Lead researcher, Professor Jian-feng Nie, from the Department of Materials Science and Engineering, said the innovative material had the potential to transform orthopaedic care by reducing complications, minimising the need for additional surgeries, and offering a sustainable alternative to permanent metallic implants.

“Our zinc alloy material could revolutionise orthopaedic care – opening the door to safer, smaller implants that not only enhance patient comfort but also promote better healing outcomes by minimising disruption to surrounding tissues,” Professor Nie said.

“An implant that never disappears will always be a risk to the patient. On the other hand, one that degrades too fast won’t allow adequate time for the bones to heal. With our zinc alloy material, we can achieve the optimal balance between strength and controlled degradation of the implant to promote better healing.”

The research shows that by engineering the size and orientation of the material’s grains, the zinc alloy can bend and adapt in unique ways to accommodate the shapes of its neighbouring tissues. 

“This made it not only stronger but more flexible, offering a game-changing alternative for orthopaedics,” Professor Nie said.

The research is paving the way for a new start-up to be launched out of Monash University with a focus on developing next-generation biodegradable implants.

https://doi.org/10.1038/s41586-024-08415-8

-ENDS-

MEDIA ENQUIRIES:

Courtney Karayannis, Media and Communications Manager

Monash University

T: +61 408 508 454 or [email protected] 



Monash University Media | +613 9903 4840 | [email protected] 

Visit Monash Lens for expert insights and commentary

 

Media

More from this category

  • Biotechnology, Science
  • 16/07/2025
  • 13:34
Brandon Capital

Brandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotechs thanks to funding from the Medical Research Future Fund

Brandon BioCatalyst’s CUREator set to support up to 15 therapeutic biotechs thanks to funding from the Medical Research Future Fund Melbourne, Wednesday 16 July:…

  • Contains:
  • Biotechnology
  • 15/07/2025
  • 17:55
Northway Biotech

AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease…

  • Contains:
  • Biotechnology
  • 11/07/2025
  • 11:39
OncoSil Medical Limited (ASX:OSL)

OncoSil Medical (ASX:OSL) announces appointment of Non-Executive Director

Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the appointment of Dr Thomas Duthy as a Non-Executive Director, effective 11 July 2025. Dr Duthy brings more than 21 years of experience across financial markets, corporate development, and board-level roles in the healthcare and life sciences sectors. He was previously Head of Corporate Development and Investor Relations at Sirtex Medical (ASX:SRX), where he played a key role in its $1.9 billion acquisition, the largest medical device transaction in Australian history. Dr Duthy is the Founder and Director of Nemean Group, a corporate advisory firm serving healthcare…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.